New monthly shot tested for schizophrenia control

NCT ID NCT05693935

Summary

This study tested a long-acting, injectable version of the medication olanzapine (called TV-44749) for adults with schizophrenia. The goal was to see if a monthly injection could effectively control symptoms and was safe to use for up to a year. Researchers compared the injection to a placebo in 675 participants to measure changes in symptom severity and daily functioning.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Teva Investigational Site 15441

    Charlotte, North Carolina, 28211, United States

  • Teva Investigational Site 15442

    Gaithersburg, Maryland, 20877, United States

  • Teva Investigational Site 15443

    Richardson, Texas, 75080, United States

  • Teva Investigational Site 15444

    San Diego, California, 92123, United States

  • Teva Investigational Site 15446

    Miami, Florida, 33155, United States

  • Teva Investigational Site 15447

    Shreveport, Louisiana, 71101, United States

  • Teva Investigational Site 15448

    Austin, Texas, 78754, United States

  • Teva Investigational Site 15449

    Santee, California, 92071, United States

  • Teva Investigational Site 15450

    Orange, California, 92868, United States

  • Teva Investigational Site 15451

    Marlton, New Jersey, 08053, United States

  • Teva Investigational Site 15452

    Miami, Florida, 33122, United States

  • Teva Investigational Site 15453

    Rogers, Arkansas, 72758, United States

  • Teva Investigational Site 15454

    Dayton, Ohio, 45417, United States

  • Teva Investigational Site 15455

    Pico Rivera, California, 90660, United States

  • Teva Investigational Site 15456

    Miami, Florida, 33155, United States

  • Teva Investigational Site 15457

    Hialeah, Florida, 33016, United States

  • Teva Investigational Site 15458

    Hollywood, Florida, 33024, United States

  • Teva Investigational Site 15459

    Bellflower, California, 90706, United States

  • Teva Investigational Site 15460

    Bentonville, Arkansas, 72712, United States

  • Teva Investigational Site 15461

    Sherman Oaks, California, 91403, United States

  • Teva Investigational Site 15462

    Miami, Florida, 33173, United States

  • Teva Investigational Site 15464

    Irving, Texas, 75062, United States

  • Teva Investigational Site 15465

    Little Rock, Arkansas, 72211, United States

  • Teva Investigational Site 15466

    Flowood, Mississippi, 39232, United States

  • Teva Investigational Site 15467

    Miami Lakes, Florida, 33016, United States

  • Teva Investigational Site 15468

    Atlanta, Georgia, 30331, United States

  • Teva Investigational Site 15469

    Decatur, Georgia, 30030, United States

  • Teva Investigational Site 15470

    Anaheim, California, 92805, United States

  • Teva Investigational Site 15471

    Riverside, California, 92506, United States

  • Teva Investigational Site 15472

    North Canton, Ohio, 44720, United States

  • Teva Investigational Site 15473

    Miami Lakes, Florida, 33016, United States

  • Teva Investigational Site 15474

    La Habra, California, 90631, United States

  • Teva Investigational Site 15477

    West Palm Beach, Florida, 33407, United States

  • Teva Investigational Site 15478

    Oklahoma City, Oklahoma, 73112, United States

  • Teva Investigational Site 15479

    Miami, Florida, 33155, United States

  • Teva Investigational Site 15480

    Chicago, Illinois, 60641, United States

  • Teva Investigational Site 15481

    Lemon Grove, California, 91945, United States

  • Teva Investigational Site 15482

    Los Angeles, California, 91436, United States

  • Teva Investigational Site 15483

    Torrance, California, 90504, United States

  • Teva Investigational Site 15484

    Miami Springs, Florida, 33166, United States

  • Teva Investigational Site 15485

    Chicago, Illinois, 60640, United States

  • Teva Investigational Site 15486

    DeSoto, Texas, 75115, United States

  • Teva Investigational Site 15487

    St Louis, Missouri, 63141, United States

  • Teva Investigational Site 15488

    Hollywood, Florida, 33021, United States

  • Teva Investigational Site 15489

    Homestead, Florida, 33030, United States

  • Teva Investigational Site 15490

    Garden Grove, California, 92845, United States

  • Teva Investigational Site 15491

    Long Beach, California, 90807, United States

  • Teva Investigational Site 15494

    Miami Lakes, Florida, 33014, United States

  • Teva Investigational Site 15495

    Miami, Florida, 33122, United States

  • Teva Investigational Site 15496

    Miami, Florida, 33176-2302, United States

  • Teva Investigational Site 15497

    Los Angeles, California, 90015, United States

  • Teva Investigational Site 15498

    Hollywood, Florida, 33021, United States

  • Teva Investigational Site 15500

    Peachtree Corners, Georgia, 30071, United States

  • Teva Investigational Site 52123

    Iași, 700282, Romania

  • Teva Investigational Site 52124

    Bucharest, 041914, Romania

  • Teva Investigational Site 52126

    Iași, 700282, Romania

  • Teva Investigational Site 52127

    Bucharest, 10825, Romania

  • Teva Investigational Site 59202

    Rousse, 7003, Bulgaria

  • Teva Investigational Site 59203

    Kazanlak, 6100, Bulgaria

  • Teva Investigational Site 59205

    Sofia, 1202, Bulgaria

  • Teva Investigational Site 59206

    Vratsa, 3000, Bulgaria

  • Teva Investigational Site 59207

    Plovdiv, 4000, Bulgaria

  • Teva Investigational Site 59208

    Lovech, 5500, Bulgaria

  • Teva Investigational Site 59209

    Veliko Tarnovo, 5000, Bulgaria

  • Teva Investigational Site 59210

    Burgas, 8000, Bulgaria

  • Teva Investigational Site 59211

    Sliven, 8800, Bulgaria

  • Teva Investigational Site 59212

    Sofia, 1377, Bulgaria

  • Teva Investigational Site 59214

    Pleven, 5800, Bulgaria

  • Teva Investigational Site 59215

    Razgrad, 7200, Bulgaria

  • Teva Investigational Site 82057

    Bursa, 16059, Turkey (Türkiye)

  • Teva Investigational Site 82058

    Adapazarı, 54290, Turkey (Türkiye)

  • Teva Investigational Site 82059

    Ankara, 6010, Turkey (Türkiye)

  • Teva Investigational Site 88044

    Hangzhou, 310012, China

  • Teva Investigational Site 88052

    Beijing, 100088, China

  • Teva Investigational Site 88053

    Shanghai, 200030, China

  • Teva Investigational Site 88054

    Tianjin, 300222, China

  • Teva Investigational Site 88055

    Jining Shi, 272051, China

  • Teva Investigational Site 88060

    Hefei, 230022, China

  • Teva Investigational Site 88064

    Zhumadian, 463002, China

  • Teva Investigational Site 88068

    Nanchang, 330046, China

  • Teva Investigational Site 88071

    Wuhan, 430030, China

  • Teva Investigational Site 88072

    Xinxiang, 453003, China

Conditions

Explore the condition pages connected to this study.